Language

English

Publication Date

4-1-2024

Journal

Annals of Clinical and Translational Neurology

DOI

10.1002/acn3.51963

PMID

38504481

PMCID

PMC11021672

PubMedCentral® Posted Date

3-19-2024

PubMedCentral® Full Text Version

Post-print

Abstract

ATP1A1 encodes a sodium-potassium ATPase that has been linked to several neurological diseases. Using exome and genome sequencing, we identified the heterozygous ATP1A1 variant NM_000701.8: c.2707G>A;p.(Gly903Arg) in two unrelated children presenting with delayed motor and speech development and autism. While absent in controls, the variant occurred de novo in one proband and co-segregated in two affected half-siblings, with mosaicism in the healthy mother. Using a specific ouabain resistance assay in mutant transfected HEK cells, we found significantly reduced cell viability. Demonstrating loss of ATPase function, we conclude that this novel variant is pathogenic, expanding the phenotype spectrum of ATP1A1.

Keywords

Child, Humans, Autistic Disorder, Intellectual Disability, Family, Siblings, Adenosine Triphosphatases, Sodium-Potassium-Exchanging ATPase

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.